Business Context and Reporting Period
This Form 8-K Current Report was filed by The RMR Group Inc. on July 8, 2016. The filing addresses a corporate governance issue regarding the composition of the Company's Board of Directors and Audit Committee following the death of Independent Director Frederick N. Zeytoonjian.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance and does not contain financial performance data.
Material Changes
- Audit Committee Composition: The death of Director Frederick N. Zeytoonjian reduced the Audit Committee to two members.
- Regulatory Status: The Company is now noncompliant with NASDAQ Listing Rule 5605(c)(2), which mandates a minimum of three independent members on the Audit Committee.
- Notice Received: On July 8, 2016, the Company received a formal written notice of non-compliance from The NASDAQ Stock Market LLC.
Guidance, Outlook, and Risks
Management Commentary and Plan: The Board of Directors intends to identify candidates to replace Mr. Zeytoonjian and appoint a new Independent Director to the Audit Committee who satisfies listing requirements.
Cure Period: The Company has until the earlier of its next annual shareholders' meeting or June 24, 2017, to regain compliance with NASDAQ rules.
Risks: Failure to regain compliance within the cure period could result in the delisting of the Company's securities from the NASDAQ Stock Market.
Investor Verification Checklist
- Verify the timeline for the appointment of a new Independent Director to the Audit Committee.
- Confirm the date of the Company's next annual shareholders' meeting to determine the exact deadline for compliance.
- Monitor future filings for updates on the search for a replacement director or any further correspondence from NASDAQ.